CSIMarket
 


Sunwin Stevia International Inc.  (SUWN)
Other Ticker:  
 


Sunwin Stevia International's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



SUWN Net Cash Flow Margin (Jul 31 2022)
I. Quarter
(Apr 30 2022)
IV. Quarter
(Jan 31 2022)
III. Quarter
(Oct 31 2021)
II. Quarter
(Jul 31 2021)
I. Quarter
Y / Y Revenue Change 23 % 13.99 % 57.42 % 127.98 % -10.96 %
Seq. Revenue Change -2.24 % -28.29 % 8.81 % 61.25 % -9.4 %
Revenue In Millions $7.71 $7.89 $11.00 $10.11 $6.27
Net Cash Flow Margin 8.06 % -10.42 % 4.04 % 0.28 % -14.28 %
Net Cash Flow Margin Total Ranking # 986 # # 1786 # 2119 # 1
Net Cash Flow In Millions $0.62 $-0.82 $0.44 $0.03 $-0.90
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - 1475.75 % - -


Commenting First Quarter 2022 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in I. Quarter to 8.06 %, below company's average Net Cash Flow Margin.

Observing first quarter 2022 results within Major Pharmaceutical Preparations industry 95 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 986.

SUWN's Net Cash Flow Margin first quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 96
Healthcare Sector # 195
Overall # 979

Net Cash Flow Margin Statistics
High Average Low
19.37 % 8.67 % 0.28 %
(Apr 30 2021)   (Oct 31 2021)




Other Net Cash Flow Margin Profitability Ratios
SUWN's Cumulative Net Cash Flow Margin
Major Pharmaceutical Preparations Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
SUWN's Net Cash Flow Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for SUWN's Competitors
Net Cash Flow Margin Profit Margin for Sunwin Stevia International's Suppliers
Net Cash Flow Margin Profit Margin for SUWN's Customers

You may also want to know
SUWN's Annual Growth Rates SUWN's Profitability Ratios SUWN's Asset Turnover Ratio SUWN's Dividend Growth
SUWN's Roe SUWN's Valuation Ratios SUWN's Financial Strength Ratios SUWN's Net Cash Flow Growth
SUWN's Roa SUWN's Inventory Turnover Ratio SUWN's Growth Rates SUWN's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Jul 31 2022, within Major Pharmaceutical Preparations Industry Net Cash Flow MarginJul 31 2022 MRQ Net Cash FlowJul 31 2022 MRQ Revenue
Skinvisible Inc   19.97 %$ 0.041 $ 0.205 
Harrow Inc   19.25 %$ 4.490 $ 23.323 
Alnylam Pharmaceuticals Inc   18.45 %$ 41.476 $ 224.818 
Orgenesis Inc   17.23 %$ 1.241 $ 7.201 
Abbvie inc   16.62 %$ 2,423.000 $ 14,583.000 
Janone Inc   16.35 %$ 1.723 $ 10.538 
Chemocentryx Inc.  16.23 %$ 3.819 $ 23.526 
Elanco Animal Health Inc  14.02 %$ 165.000 $ 1,177.000 
Ptc Therapeutics inc   13.63 %$ 22.567 $ 165.526 
Rvl Pharmaceuticals Plc  12.69 %$ 1.072 $ 8.448 
Harmony Biosciences Holdings inc   11.24 %$ 12.034 $ 107.028 
Abbott Laboratories  11.21 %$ 1,262.000 $ 11,257.000 
Intercept Pharmaceuticals inc   10.50 %$ 7.533 $ 71.757 
Amarin Corp Plcuk  9.37 %$ 8.850 $ 94.440 
International Stem Cell Corporation  9.27 %$ 0.188 $ 2.027 
Cumberland Pharmaceuticals Inc  9.22 %$ 0.950 $ 10.299 
Rigel Pharmaceuticals Inc  8.46 %$ 2.522 $ 29.819 
Collegium Pharmaceutical Inc   8.23 %$ 16.024 $ 194.734 
Sunwin Stevia International Inc.  8.06 %$ 0.622 $ 7.710 
Merck and Co Inc   7.81 %$ 1,139.000 $ 14,593.000 
Ultragenyx Pharmaceutical Inc   7.29 %$ 6.510 $ 89.343 
Mallinckrodt Plc  6.11 %$ 23.400 $ 382.900 
Lifevantage Corp  4.70 %$ 2.394 $ 50.943 
Ainos Inc   4.25 %$ 0.027 $ 0.637 
Emmaus Life Sciences Inc   3.94 %$ 0.169 $ 4.287 
Organogenesis Holdings Inc   3.66 %$ 4.442 $ 121.401 
Prestige Consumer Healthcare Inc   3.13 %$ 8.684 $ 277.059 
Biomarin Pharmaceutical Inc  2.69 %$ 14.362 $ 533.798 
Amicus Therapeutics inc   2.52 %$ 2.038 $ 80.731 
Eli Lilly And Company  2.52 %$ 163.700 $ 6,488.000 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com